{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:00Z","timestamp":1786991280195,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jad.2021.03.053","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:21:53Z","timestamp":1616782913000},"page":"210-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-7951","authenticated-orcid":false,"given":"Orly","family":"Lipsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S.","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartej","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna M.W.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehala","family":"Subramaniapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kratiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-4493","authenticated-orcid":false,"given":"Roger","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2021.03.053_bib0001","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/da.22249","article-title":"What is the threshold for a clinically relevant effect? The case of major depressive disorders","volume":"31","author":"Cuijpers","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2021.03.053_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-3956(99)00037-0","article-title":"The responsiveness of the Hamilton Depression Rating Scale","volume":"34","author":"Faries","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2021.03.053_bib0003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0004","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1176\/appi.ajp.2015.14050652","article-title":"Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters","volume":"172","author":"Guo","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2020.01.108","article-title":"Concordance between clinician-rated and patient reported outcome measures of depressive symptoms in treatment resistant depression","volume":"266","author":"Hershenberg","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.03.053_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/bdi.13026","article-title":"In vivo phenotyping, mechanism-informed treatments, domain-based psychopathology and nomological networks: A strategy for treatment discovery and development in bipolar depression","volume":"22","author":"McIntyre","year":"2020","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jad.2021.03.053_bib0006","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis","volume":"276","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.03.053_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/da.22063","article-title":"Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions","volume":"30","author":"McIntyre","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2021.03.053_bib0007","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1503\/cmaj.050786","article-title":"Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale","volume":"173","author":"McIntyre","year":"2005","journal-title":"CMAJ"},{"issue":"Suppl 1","key":"10.1016\/j.jad.2021.03.053_bib0008","first-page":"20","article-title":"Treating to target in major depressive disorder: response to remission to functional recovery","volume":"20","author":"McIntyre","year":"2015","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jad.2021.03.053_bib28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bdi.12941","article-title":"The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder","volume":"22","author":"McIntyre","year":"2020","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jad.2021.03.053_bib0009","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jad.2020.05.088","article-title":"The Effectiveness of Repeated Intravenous Ketamine on Depressive Symptoms, Suicidal Ideation and Functional Disability in Adults with Major Depressive Disorder and Bipolar Disorder: Results from the Canadian Rapid Treatment Center of Excellence","volume":"274","author":"McIntyre","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.03.053_bib31","doi-asserted-by":"crossref","unstructured":"McIntyre, R.S., Rosenblat, J.D., Nemeroff, C.B., Sanacora, G., Murrough, J.W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., Iosifescu, D.V., Lopez Jaramillo, C., Kasper, S., Kratiuk, K., Lee, J.G., Lee, Y., Lui, L.M.W., Mansur, R.B., Papakostas, G.I., Subramaniapillai, M., Thase, M., Vieta, E., Young, A.H., Zarate, C.A., Jr, Stahl, S., 2021. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. Am. J. Psychiatry appiajp202020081251.","DOI":"10.1176\/appi.ajp.2020.20081251"},{"key":"10.1016\/j.jad.2021.03.053_bib0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2021.03.053_bib0011","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0012","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0013","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12889","article-title":"Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis","volume":"81","author":"Papakostas","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2020.03.020","article-title":"Registered clinical trials investigating ketamine for psychiatric disorders","volume":"127","author":"Peyrovian","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2021.03.053_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S1092852919001159","article-title":"Keeping up with the clinical advances: depression","volume":"24","author":"Ragguett","year":"2019","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jad.2021.03.053_bib0016","first-page":"1","article-title":"Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence","author":"Rodrigues","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2021.03.053_bib0017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2018.09.027","article-title":"Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression","volume":"243","author":"Rosenblat","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.03.053_bib0018","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.comppsych.2005.03.001","article-title":"Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores","volume":"46","author":"Ruh\u00e9","year":"2005","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0019","doi-asserted-by":"crossref","DOI":"10.1176\/appi.focus.18207","article-title":"Improving Depression Outcome by Patient-Centered Medical Management","author":"Rush","year":"2020","journal-title":"FOCUS"},{"key":"10.1016\/j.jad.2021.03.053_bib0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0021","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1092852919001470","article-title":"Dextromethorphan\/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity","volume":"24","author":"Stahl","year":"2019","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jad.2021.03.053_bib0022","series-title":"Applied Multivariate Statistics for the Social Sciences","author":"Stevens","year":"2012"},{"key":"10.1016\/j.jad.2021.03.053_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/da.20058","article-title":"A three-factor model of the MADRS in major depressive disorder","author":"Suzuki","year":"2005","journal-title":"Depression and Anxiety"},{"issue":"Suppl 13","key":"10.1016\/j.jad.2021.03.053_bib0024","first-page":"23","article-title":"When at first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.61.7.669","article-title":"Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project","volume":"61","author":"Trivedi","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2021.03.053_bib0026","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2021.03.053_bib0027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jad.2013.10.020","article-title":"Dimensions in major depressive disorder and their relevance for treatment outcome","volume":"155","author":"Vrieze","year":"2014","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721002792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721002792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:57:31Z","timestamp":1759024651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032721002792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":31,"alternative-id":["S0165032721002792"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2021.03.053","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2021.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}